> Agenda 2011


09.00 am	Registration & poster exhibition opens The poster exhibition will be open all day

09.30 – 09.40 am	Welcome & opening remarks Dr Christian Stein, Ascenion GmbH

09.40 – 10.40 am	Presentation stream 1 Diagnostics Chair: Dr Jürgen Walkenhorst, Provendis GmbH H2 Novel contrast agents for Magnetic Resonance Imaging, Dr Irene Mavridis, NCSR Demokritos N1 Protein biomarkers for a non-invasive diagnosis of pancreatic cancer, Dr Christoph Schröder, DKFZ T4 RINF as a prognostic marker of survival in some Leukemia subtypes, Thomas Aloysius, University of Bergen W1 Rabbit monoclonal antibodies for cervical cancer screening, Prof. Pidder Jansen-Dürr, Österreichische Akademie der Wissenschaften W2 Pan-AC and Pan-fungus detection assays, Sandra Preuner, Children´s Cancer Research Institute, St. Anna Kinderkrebsforschung C1 Method for identifying myocardially-infarcted patients having increased risk of developing a heart condition, Dr Philippe De Backer, CRP-Santé

10.40 – 11.10 am	Poster session – Ask the experts

11.10 – 12.20 pm	Presentation stream 2 Neurological Disorders, Metabolism & Tools Chair: Dr Despina Yancopoulou, Hellenic Bio Cluster -- Inlicensing needs of TEVA Pharmaceutical Industries Ltd., Paul Leijten, M.D., Senior Partnering Director H6 Novel spirosteroid molecules with strong neuro-protective and neuro-regenerative activities, Dr Constantinos Neofytou, Bionature E.A. Ltd I1 Drug screening assay for the detection of Aß 42 peptides in the cell nucleus, Prof. Gerd Multhaup, Freie Universität Berlin I2 C3bot peptides for the treatment of traumatic or degenerative neuronal injury, Dr Markus Höltje, Charité-Universitätsmedizin Berlin L1 TRPM8 antagonists for the treatment of overactive bladder and pain, Dr Patrick Chaltin, KULeuven D1 Monoclonal antibodies against the TrkB receptor as a treatment of Cachexia or Anorexia Nervosa, Prof. Karl Hofbauer, Biozentrum, University of Basel T1 Biopolymer-based enhancement of molecular detection technologies, Dr Christian Dölle, Universitetet i Bergen

12.20 – 12.50 pm	Poster session – Ask the experts

12.20 – 01.45 pm	Lunch

01.45 – 02.30 pm	Spin-off Panel BioVaria-Spin-off Award sponsored by MLawGroup Short introduction of the MLawGroup, Rainer Kreifels, Partner Moderator: Sam Ogunsalu, Principal Executive Commercial Development, Queen Mary Innovations, U.K.

02.30 – 03.30 pm	Presentation stream 3 Infection & Immunology Chair: Dr Philippe de Backer, CRP-Santé -- Inlicensing needs of MSD, Dr Manfred Horst, Director Scientific Liason B1 Identification of cytotoxic CD8+ T cell antigens, Prof. Klaus Dornmair, LMU Munich P2 PLA–Inhibitor (stoPLA), Prof. Matthias Lehr, University of Muenster S2 Methods and compositions such as pharmaceutical compositions for treating glomerulonephritis, Sébastien Chaffre, Inserm Transfert A2 SALP Peptides are potent broad-spectrum antiviral agents, Prof. Klaus Brandenburg, Research Center Borstel P1 Compounds activating the glmS riboswitch as new antibacterial targets, Christina E. Lünse, LIMES Institute, Rheinische Friedrich-Wilhelms-Universität Bonn

03.30 – 04.00 pm	Poster session – Ask the experts

04.00 – 05.00 pm	Presentation stream 4 Oncology & Drug Development Chair: Dr. Stéphane Mottola, FIST S.A. -- Inlicensing needs of Bayer Schering, Dr Joerg Knäblein, Technology Scouting A1 Argyrin – A promising novel anti-cancer compound, Prof. Nisar Malek, Medizinische Hochschule Hannover B2 New Combretastatin Analogs - chemotherapeutic agents against multidrug resistant cancer, Prof. Rainer Schobert, University Bayreuth F2 New monoclonal antibody for cancer therapy, Dr Patricia Rousselle, CNRS, Université Claude Bernard F4 Novel marker of resistance to chemotherapy, Dr Nathalie Mazure, CNRS) M1 Novel selective inhibitors of Cyclin-dependent Kinase 7 (CDK7), Dr Bert Klebl, Lead Discovery Center GmbH

05.00 – 05.30 pm	Poster session – Ask the experts

05.30 pm	BioVaria Spin-off Award Ceremony

06.00 pm	Poster exhibition closes